OSI 027

CREB regulated transcription coactivator 2 ; Mus musculus







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35472745 Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism. 2022 Apr 26 1
2 33222668 OSI-027 Alleviates Oxaliplatin Chemoresistance in Gastric Cancer Cells by Suppressing P-gp Induction. 2021 2
3 33836346 Effects of rapamycin and OSI-027 on α-SMA in lung tissue of SD rat pups with hyperoxic lung injury. 2021 Jun 4 1
4 30650200 Targeting mTORC1/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes. 2019 Mar 1
5 27002938 A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies. 2016 Apr 12 2
6 27212159 Inhibition of mTOR suppresses human gallbladder carcinoma cell proliferation and enhances the cytotoxicity of 5-fluorouracil by downregulating MDR1 expression. 2016 May 1
7 26026051 Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells. 2015 Aug 3
8 26213847 OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo. 2015 Sep 22 1
9 26284306 The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2. 2015 Oct 3
10 22080480 Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies. 2012 Jan 12 2
11 21363918 Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors. 2011 Mar 1 1
12 21415215 Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors. 2011 Jul 1 1
13 21673091 Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin. 2011 Aug 3
14 20616057 Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells. 2010 Jul 13 1
15 20699667 Induction of autophagy by dual mTORC1-mTORC2 inhibition in BCR-ABL-expressing leukemic cells. 2010 Oct 1